ENTRADA THERAPEUTICS INC's ticker is and the CUSIP is 29384C108. A total of 49 filers reported holding ENTRADA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $330,947 | -26.9% | 20,946 | -30.0% | 0.00% | – |
Q2 2023 | $452,730 | -25.2% | 29,903 | -28.4% | 0.00% | – |
Q1 2023 | $605,637 | +80.0% | 41,768 | +67.8% | 0.00% | – |
Q4 2022 | $336,460 | +102.7% | 24,886 | +136.3% | 0.00% | – |
Q3 2022 | $166,000 | -35.7% | 10,530 | -50.3% | 0.00% | – |
Q2 2022 | $258,000 | +230.8% | 21,185 | +153.4% | 0.00% | – |
Q1 2022 | $78,000 | +9.9% | 8,361 | +100.9% | 0.00% | – |
Q4 2021 | $71,000 | – | 4,162 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 4,425,784 | $64,173,868 | 26.74% |
5AM Venture Management, LLC | 4,408,379 | $63,921,496 | 16.35% |
72 Investment Holdings, LLC | 509,023 | $7,380,833 | 3.50% |
StepStone Group LP | 761,277 | $11,038,517 | 2.05% |
TCG Crossover Management, LLC | 584,955 | $8,481,848 | 1.65% |
Redmile Group, LLC | 1,831,608 | $26,558,316 | 1.15% |
Nan Fung Group Holdings Ltd | 73,582 | $1,066,939 | 0.73% |
Baker Brothers Advisors | 4,865,819 | $70,554,376 | 0.38% |
CHI Advisors LLC | 56,374 | $817,423 | 0.22% |
MOORE CAPITAL MANAGEMENT, LP | 105,000 | $1,522,500 | 0.03% |